UnknownNot Applicable

Application of Three- Dimensional Visualization Combined With ICG Molecular Fluorescence Imaging in Hepatolithiasis

China100 participantsStarted 2024-08-30

Plain-language summary

This study adopted a retrospective study method to explore the clinical application value of 3D visualization combined with ICG molecular fluorescence imaging technology in hepatolithiasis, and further analyze whether 3D visualization combined with ICG molecular fluorescence imaging technology can improve the prognosis of hepatolithiasis by comparing with conventional surgery.

Who can participate

Age range18 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged ≥18 years, of any gender; The diagnosis was hepatolithiasis；Surgical treatment has been performed. Exclusion Criteria: * Patients with severe cardiac, pulmonary, cerebral, renal dysfunction or other clinical contraindications who are unable to tolerate surgical treatment; Patients with malignant transformation; Lack of clinical data.

What they're measuring

operation time

Timeframe: Perioperative period

intraoperative blood loss

Timeframe: Perioperative period

intraoperative incidental injuries

Timeframe: Perioperative period

Trial details

NCT IDNCT06447181

SponsorZhujiang Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-25

View on ClinicalTrials.gov More Hepatolithiasis trials